StockData
DexCom Inc logo

DexCom Inc (DXCM) income statement

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value
$82.52+0.48 (+0.59%)

Close on Nov 18, 2026Market cap $30.78BP/E 32.5Yield –

DexCom Inc income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
63.4%
Operating margin
24.0%
Net margin
19.4%
Return on equity, FY2025
34.5%

Financial strength

Current ratio
1.74
Debt to equity
–
Debt to assets
–
Cash to current liabilities
42.7%

Valuation

P/E ratio
32.5
Price to sales
6.03
Price to book
12.14
Dividend yield
–

See a number that looks wrong?